Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Venus Medtech (Hangzhou) Inc.
  6. News
  7. Summary
    2500   CNE100003PJ8

VENUS MEDTECH (HANGZHOU) INC.

(2500)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Venus Medtech Hangzhou : VOLUNTARY ANNOUNCEMENT UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2021 TO JUNE 30, 2021

07/26/2021 | 05:18am EDT

Pursuant to the Codes on Takeovers and Mergers and Share Repurchases ('Takeovers Codes'), a copy of each document to be displayed under Note 1 to Rule 8 of the Takeovers Codes must be provided by the issuer of the offer document or offeree board circular, as appropriate, to Securities and Futures Commission ('SFC') for display on the SFC's website. To access these documents on display, you can either click this link https://www.sfc.hk/dod/jsp/EN/DoDmain.jsp or click the View Documents on Displaybutton next to the subject title of the offer document or offeree board circular.

Some of the files are prepared in the portable document format and viewing them requires Adobe(R) Reader(R) which can be downloaded free of charge.

Disclaimer

Venus MedTech HangZhou Inc. published this content on 26 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 July 2021 09:17:06 UTC.


ę Publicnow 2021
All news about VENUS MEDTECH (HANGZHOU) INC.
08/31Venus Medtech Hangzhou Inc. Reports Earnings Results for the Half Year Ended June 30, 2..
CI
08/31Venus Medtech Inc. Announces Unaudited Consolidated Earnings Results for the Six Months..
CI
08/16VENUS MEDTECH HANGZHOU : Unveils Plan to Buy Medical Device Research and Development Busin..
MT
07/27VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal Investigato..
AQ
07/27VENUS MEDTECH HANGZHOU : Appoints Professor Martin B. Leon as Global Principal Investigato..
PR
07/27Venus Medtech Inc. Appoints Martin B. Leon as the Global Principal Investigator of RDN ..
CI
07/26VENUS MEDTECH HANGZHOU : Voluntary announcement unaudited operating statistics for the per..
PU
07/26Venus Medtech Inc. Announces Unaudited Group Revenue Results for the Six Months Ended J..
CI
06/30Venus Medtech Inc. Announces Formation of Joint Venture Company with Healium Medical Lt..
CI
05/06VENUS MEDTECH HANGZHOU : Voluntary announcement latest investment project
PU
More news
Financials
Sales 2021 554 M 85,8 M 85,8 M
Net income 2021 -152 M -23,5 M -23,5 M
Net cash 2021 2 429 M 376 M 376 M
P/E ratio 2021 -98,5x
Yield 2021 -
Capitalization 14 944 M 2 311 M 2 314 M
EV / Sales 2021 22,6x
EV / Sales 2022 12,7x
Nbr of Employees 675
Free-Float 76,4%
Chart VENUS MEDTECH (HANGZHOU) INC.
Duration : Period :
Venus Medtech (Hangzhou) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VENUS MEDTECH (HANGZHOU) INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 33,89 CNY
Average target price 60,45 CNY
Spread / Average Target 78,4%
EPS Revisions
Managers and Directors
Zhen Jun Zi Executive Director & General Manager
Haiyue Ma Chief Financial Officer & Joint Secretary
Min Zeng Chairman
Yan Xiao Chairman-Supervisory Board
Hou-Sen Lim Chief Operating Officer, Executive Director & CTO
Sector and Competitors